I had a play in the ImpediMed website some months ago, and there...

I had a play in the ImpediMed website some months ago, and there was a lot of information in there.

Also is good to monitor the lymphedema patient awareness sites, eg. Even in YouTube, there are good videos with lots of very well- explained information with new ones daily , posted by registered Lymphedema therapists- with prevention and good management information.

Many facilities in key states in the US, eg California were advertising for a lymphedema therapist, at physical therapy clinics for cancer survivors, and explicitly state that the successful applicant will manage Sozo machine testing and the physical monitoring and care and therapy + treatment needs lymphedema patients. Remembering that now the individually made and must be professionally fitted pressure garments needing to be worn daily by lymphedema sufferers, are now all covered with reimbursement by the private health insurers and Medicaid already.
This reimbursement status has been gained, and is sentient for full reimbursement status occurring ahead now for Sozo BIS tests. As requirement, duty of care , and medically necessary as per NCCN survivorship cancer treatment and care updated guidelines.

Re the website- I am sure that it is in there, that you can put in a postcode, US town for instance, and up comes the nearest location for a Sozo monitoring system and facility where is in place.
It was heartening to see the coverage actually, randomly picking states across the USA. Notably in key states I found one within 200kms, main population areas, key large state cities.

Also in Australia and in New Zealand.
Very good access for all post- cancer patients now actually and breast cancer patients I would think in main areas.
And I have seen ads even on a sign in a town for lymphedema awareness and specialised management in local town public health clinic.
So we mustn’t forget our own country and important monitoring and care needs of all cancer patients and survivors here, in Aust and NZ.
Singapore, other main Asia ?, as well as early adoption in key European locations, eg. The Netherlands.